Abstract

Successful pregnancy outcomes have been reported after all types of solid organ transplantation (1-7). As immunosuppressive agents and medications for other comorbidities (i.e., hypertension, diabetes, etc.) are required in transplant recipients, concerns for pregnancy in this population include the effects of these medications on the developing fetus. Additional concerns relate to the effect of pregnancy on the well-being of the mother and the transplanted organ. Although there are real risks to the mother, the transplanted organ, and the fetus, successful pregnancies are likely in transplant recipients in the presence of stable graft function and with adequate control of comorbidities (8). Thus far, there does not appear to be an increase in the type or incidence of congenital malformations. Most pregnancies proceed without evidence of graft dysfunction and/or irreversible deterioration in graft function.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.